Maria G. Gotsch is President and Chief Executive Officer of the Partnership Fund for New York City (www.pfnyc.org), which is the investment arm of the Partnership for New York City. The Fund, which has invested over $170 million, has built a network of top experts from the investment and corporate communities who help identify and support New York City’s most promising entrepreneurs in both the for-profit and non-for profit sectors. In addition to leading the Fund’s operations, Maria has spearheaded the creation and operation of a number of the Fund’s strategic initiatives, including: FinTech Innovation Lab; New York Digital Health Accelerator; Transit Tech Lab; NY Fashion Tech Lab; NYCSeed (seed financing for IT/digital media companies); BioAccelerate Prize NYC (proof-of-concept funding for university-based biomedical research); Arts Entrepreneurial Loan Fund (low cost loans for mid-size arts groups); and ReStart Central and Financial Recovery Fund (assistance and funding for small businesses impacted by 9/11/01).

Prior to joining the Fund in 1999, Maria was a Managing Director at BT Wolfensohn (now part of Deutsche Bank), providing strategic and financial advice related to mergers, acquisitions, dispositions, joint ventures and the development of business strategies. Before starting with Wolfensohn, Maria worked at LaSalle Partners in the New York area and for Merrill Lynch Capital Markets in New York and London. Maria has an MBA from Harvard Business School and a B.A. from Wellesley College. She was also the recipient of a Fulbright Fellowship to study international relations at the Institut Universitaire de Hautes Etudes Internationales in Geneva, Switzerland.

Maria also is a member of the boards of Sonepar USA Holdings and the New York Venture Capital Association; serves on the audit committee of Sonepar S.A.; and, serves on the advisory boards of ProPublica (investigative journalism non-profit), Schools That Can, Columbia University’s Lang Fund and Hospital for Special Surgery Innovation Advisory Council.

An architect by training, Sally has a reputation for bringing great creativity, innovation and attention to detail to every project she works on, including some of HDR’s most high-profile education, science, workplace, and mixed-use projects around the globe. In her role as Education & Science leader, she directs and executes regional project leadership, strategic planning and business development efforts to help life science corporations and developers achieve their missions and goals.

Martin L. Togni is a partner in the San Diego office of Allen Matkins with a practice focusing primarily on Life Sciences, representing a variety of landlords and tenants in the development and leasing of Life Science and Biotech projects. He has successfully completed major leasing transactions totaling more than 40 million square feet in California, the Midwest, and East Coast over the past 25 years, representing some of the nation's leading real estate and end-user companies. Martin also represents a wide variety of clients in the acquisition, disposition, development, financing and ground leasing of shopping centers, industrial projects, office buildings and other commercial and mixed-use projects throughout the country

Arslan Asovic is a Science and Technology Practice Area Leader for Syska Hennessy Group in our NYC office. He has Over 22 years of experience leading cross-functional teams throughout all stages of site selection, design, construction, testing and commissioning, and completion. Arslan’s main areas of expertise include the design of state-of-the-art laboratories and research facilities for academia and healthcare institutions. He is humbled that he was involved in design of a laboratory where a researcher was awarded with a Nobel Prize for conducting lifesaving research. Arlsan is an active member of I2SL and ASHRAE

Dan Davis serves as a Senior Associate at JB&B, with a primary focus on life science process engineering. Since joining the firm in 2022, he has been a driver in the firm’s growth in the life

sciences industry. He has led the process utility efforts for a cell and gene therapy (CGT) contract development and manufacturing company (CDMO) multi-facility project. In addition to process engineering, he was has been the project manager for on projects that have included cGMP plasmid facilities, iPSC labs, PCR labs, and semiconductor telecommunication labs. He has also supported previous clients by advising on the tech transfer of a vaccine facility.

Mr. Davis brings to the firm a unique perspective, having leveraging experience both from the

design firm side as an engineer and from the owner’s side as an owner’s representative. His recent projects at JB&B include: SK pharma co at The Discovery Labs, King of Prussia, PA;

Sampled at 30 Knightsbridge Road, Piscataway, NJ; Sanofi Flu Vaccine Tech Transfer, Toronto, ON; and Nokia Bell Labs, New Brunswick, NJ. He is engaged in the education community, providing support as a guest industry panelist for student presentations at Howard University and Villanova University. He has provided an AIA CEC lecture on S&T 100 Design Considerations for Clean Rooms, and for Interphex 2024 he will be a moderating the a panel discussing pharmaceutical manufacturing in urban centers. Mr. Davis earned his Bachelor of Science degree in Chemical Engineering from Drexel University.

R.P. Brennan, General Contractors/Construction Managers

2021-Present Executive Vice-President, Corporate Strategy & Business Development

 Lead the design and execution of major business transformation initiatives to develop the company’s long and short-term objectives, elevate business performance, strengthen the company’s operational model, profit optimization, and growth opportunities.

 Identify trends and opportunities in the various construction sectors which the company serves, and seek out new sectors which the company can enter and scale the company’s business.

 Provide strategic thinking and execution in business development, sales and marketing, and operations management.

Madison Advisory Group LLC

2005-Present Principal

 Strategic consultant to real estate owners including the workout and restructuring of debt/equity structures of small and large scale office and multi-family residential projects, and the construction industry.

 Built over 2,500 residential units in multiple rental and condominium development and conversion projects in New York City.

 Lead coordinator of all aspects of the multi-family rental and condominium development process including acquisition and financing, preparation of condominium offering plans, architecture/design/engineering matters, construction of the property, and marketing and sales of the apartment units.

Swig Equities, LLC / Helmsley Spear, LLC, New York, NY

2006-2018 Executive Vice-President, Chief Operating Officer

 With Swig Equities, directed the day-to-day business of this real estate investment,

development, and property management company, coordinating capital and operating expenditures in the development, ownership, management strategies of a 4+ million square foot portfolio of office buildings.

 Led all aspects of the development of 1,000 apartments in 2 large-scale projects with End-to-End experience in the acquisition, financing, architecture/engineering,

reconstruction/renovation, and marketing and sales of large-scale condominium

conversion projects.

 With Helmsley Spear, LLC, lead the day-to-day operations of a 30 broker team, human capital management, and tracking deal pipeline.

Metro Loft Management, LLC, New York, NY

2003-2006 Chief Operating Officer; General Counsel

 Metro Loft Management, LLC is a diversified real estate development company

principally involved in the ownership, development, and conversion from office to

residential use.

 Led the end-to-end acquisition, financing, architectural, construction, marketing and leasing components of 3 multi-family development projects totaling over 1.5 million square feet of multi-the construction of over 1,300 apartments.

EDUCATION: Legal: University of Toledo College of Law Brooklyn Law School

Toledo, Ohio Brooklyn, New York

Juris Doctor Visiting Student

College: Syracuse University

Syracuse, New York

Ed Jaram joined King Street at the start of 2019 to manage project execution in New York and the surrounding markets, and has nearly 20 years’ experience in construction and real estate, both in the US and the UK. Before joining King Street, he ran the in-house construction company for a Manhattan-based developer performing both ground-up and renovation projects, delivering over 1,000,000 sq ft of construction in a three-year period. Before that, he worked for 10 years for Gardiner & Theobald – one of the largest independently-held construction consultancies in the world – and delivered projects with a total value of over $1bn in London, Los Angeles and New York, for clients including the WPP Advertising group, BioMed Realty, and The Dorchester Collection hotel company.

Josh has over 37 years of experience in the industry. 35 years of it within the science & technology markets. This has provided him with a unique blend of experience including projects for life science, academic, micro-electronic, bio-medical, medical device, pharmaceutical, mission critical, R&D laboratories, and cleanrooms. These projects include: BSL-4, BSL-3 and BLSL-2 laboratories, vivarium, cGMP manufacturing spaces and cleanroom (class 10,000 to class 1) environments. With significant experience in strategic planning, business development, project leadership and management, budgeting, scheduling, construction administration and facilitation of life science/advanced technology projects, he has been able to skillfully integrate client and stakeholder needs and transform them into built solutions.

Susan Rosenthal is the Senior Vice President, Life Sciences & Healthcare at the New York City Economic Development Corporation, which announced in June 2021 a plan to double the City’s $500 million investment in life sciences to $1 billion to create jobs and establish New York City as a global leader in life sciences. Susan also led NYCEDC’s COVID-19 testing team, which in partnership with City Hall and NYC Health + Hospitals helped launch the Pandemic Response Lab, created a local supply chain for COVID test kits, and evaluated technologies for point of care and rapid tests to support the City’s response to COVID-19. Susan has over fifteen years of industry experience with a rich background in business development, corporate strategy, and portfolio management from her time at Pfizer and Deloitte Consulting. Her experience spans many therapeutic areas as well as across early and late stage R&D. Sue earned her MBA from NYU and her Bachelor's degree in economics from the Massachusetts Institute of Technology.